Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Wild

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Technology Assessment in Health Care|June 9, 2009
Austria: history of health technology assessment during the past 20 yearsClaudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|October 21, 2009
[Development and institutionalization of Health Technology Assessment in Austria: the Ludwig Boltzmann Institute for Health Technology Assessment]Claudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 19, 2020
[A new definition for Health Technology Assessment, HTA, translation with commentary]Matthias Perleth, Claudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|February 15, 2016
[Not Available]Joerg Meerpohl, Claudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 14, 2013
[HTA-Perspective: Challenges in the early assessment of new oncological drugs]Claudia Wild, Anna Nachtnebel
Wiener Medizinische Wochenschrift (1946)|April 26, 2013
[HIV testing of the general population: international recommendations and actual risks for HIV infections in health occupations]Claudia Wild, Johanna Dellinger
Wiener Medizinische Wochenschrift (1946)|September 23, 2008
[Health Technology Assessment--evaluating health care interventions]Claudia Wild, Gerald Gartlehner
ESMO Open|August 30, 2017
Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?Nicole Grössmann, Claudia Wild
Journal of Market Access & Health Policy|May 10, 2019
Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemptionClaudia Eder, Claudia Wild
Health Policy (Amsterdam, Netherlands)|January 25, 2003
Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and AustriaClaudia Wild, Bernhard Gibis
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Technology Assessment in Health Care|June 9, 2009
Austria: history of health technology assessment during the past 20 yearsClaudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|October 21, 2009
[Development and institutionalization of Health Technology Assessment in Austria: the Ludwig Boltzmann Institute for Health Technology Assessment]Claudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 19, 2020
[A new definition for Health Technology Assessment, HTA, translation with commentary]Matthias Perleth, Claudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|February 15, 2016
[Not Available]Joerg Meerpohl, Claudia Wild
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 14, 2013
[HTA-Perspective: Challenges in the early assessment of new oncological drugs]Claudia Wild, Anna Nachtnebel
Wiener Medizinische Wochenschrift (1946)|April 26, 2013
[HIV testing of the general population: international recommendations and actual risks for HIV infections in health occupations]Claudia Wild, Johanna Dellinger
Wiener Medizinische Wochenschrift (1946)|September 23, 2008
[Health Technology Assessment--evaluating health care interventions]Claudia Wild, Gerald Gartlehner
ESMO Open|August 30, 2017
Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?Nicole Grössmann, Claudia Wild
Journal of Market Access & Health Policy|May 10, 2019
Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemptionClaudia Eder, Claudia Wild
Health Policy (Amsterdam, Netherlands)|January 25, 2003
Evaluations of health interventions in social insurance-based countries: Germany, the Netherlands, and AustriaClaudia Wild, Bernhard Gibis
Pageof 9